Pharmaceutical Preparations · A1 · CIK 1582313
Xenon Pharmaceuticals discovers, develops, and commercializes neuroscience therapeutics for patients in need
Comparable business profile · signals at a glance
In the 90 days to Mar 13, 2026: 3 sold $19.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 13, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 7,308 | $55.23 | $404K |
| Mar 13, 2026 | Kenney Christopher JohnChief Medical Officer | Sell | 1,410 | $55.23 | $78K |
| Mar 13, 2026 | Difabio AndreaChief Legal Officer | Sell | 1,342 | $55.23 | $74K |
| Mar 10, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 11,269 | $60.11 | $677K |
| Mar 10, 2026 | Kenney Christopher JohnChief Medical Officer | Sell | 2,771 | $60.11 | $167K |
| Mar 10, 2026 | Difabio AndreaChief Legal Officer | Sell | 2,607 | $60.11 | $157K |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 65,000 | $62.06 | $4.0M |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 61,652 | $60.08 | $3.7M |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 43,348 | $59.26 | $2.6M |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 31,694 | $59.88 | $1.9M |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 21,515 | $60.49 | $1.3M |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 21,791 | $58.81 | $1.3M |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 12,479 | $59.50 | $743K |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 10,072 | $60.47 | $609K |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 2,449 | $61.26 | $150K |
| Jan 2, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 37,938 | $44.40 | $1.7M |
| Jan 2, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 2,062 | $44.93 | $93K |
| Dec 8, 2025 | Mortimer IanPRESIDENT & CEO | Sell | 8,820 | $45.59 | $402K |
| Dec 8, 2025 | Mortimer IanPRESIDENT & CEO | Sell | 2,010 | $46.32 | $93K |
| Dec 5, 2025 | Mortimer IanPRESIDENT & CEO | Sell | 14,375 | $45.03 | $647K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.